Mobidiag Ltd:企業の製品パイプライン分析

◆英語タイトル:Mobidiag Ltd - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME16989PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company’s products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag’s Prove-it products include prove-it sepsis, prove-it bone and joint, and prove-it herpes for the detection and analysis of the microarrays. The company’s target therapy areas comprise in vitro diagnostics, gastrointestinal infections, and other infectious diseases. The company has operations in Finland, Sweden, the UK and France. Mobidiag is headquartered in Espoo, Finland.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Mobidiag Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Mobidiag Ltd Company Overview
Mobidiag Ltd Company Snapshot
Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
Mobidiag Ltd – Pipeline Analysis Overview
Mobidiag Ltd – Key Facts
Mobidiag Ltd – Major Products and Services
Mobidiag Ltd Pipeline Products by Development Stage
Mobidiag Ltd Pipeline Products Overview
Amplidiag RESP-4
Amplidiag RESP-4 Product Overview
GeneSpress
GeneSpress Product Overview
Novodiag Cartridge – Meningitis
Novodiag Cartridge – Meningitis Product Overview
Novodiag COVID-19 + InfA/B
Novodiag COVID-19 + InfA/B Product Overview
Novodiag RESP-4
Novodiag RESP-4 Product Overview
Novodiag System – Bloodstream Infections
Novodiag System – Bloodstream Infections Product Overview
Novodiag System – Central Nervous System Infections
Novodiag System – Central Nervous System Infections Product Overview
Novodiag System – Respiratory Infections
Novodiag System – Respiratory Infections Product Overview
Novodiag System – Sepsis
Novodiag System – Sepsis Product Overview
Novodiag System – Skin And Soft Tissue Infections
Novodiag System – Skin And Soft Tissue Infections Product Overview
Mobidiag Ltd – Key Competitors
Mobidiag Ltd – Key Employees
Mobidiag Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Mobidiag Ltd, Recent Developments
Feb 11, 2020: Mobidiag initiates development of molecular test for coronavirus
Feb 11, 2020: Mobidiag initiates development of molecular test for coronavirus
Jan 07, 2020: Mobidiag secures additional funding from Business Finland for rapid sepsis diagnostic test
Dec 11, 2019: Mobidiag Symposium on Innovative Molecular Diagnostics to be held for third year at RICAI annual meeting
Oct 29, 2019: Mobidiag signs new international agreements for distribution of its Amplidiag and Novodiag Diagnostic Solutions
Oct 10, 2019: Mobidiag’s Novodiag Stool Parasites test secures CE-IVD Mark
Jul 01, 2019: Mobidiag signs exclusive agreement with Pro Med Diagnostics for the distribution of Amplidiag and Novodiag Diagnostic Solutions in Africa
Jun 03, 2019: Mobidiag announces launch of Automobi Molecular Diagnostics
May 14, 2019: Investment Plan for Europe: Mobidiag secures EUR 25 Million from EIB
Mar 19, 2019: Mobidiag to attend the 29th European Congress of Clinical Microbiology & Infectious Diseases in Amsterdam, the Netherlands
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Mobidiag Ltd Pipeline Products and Ongoing Clinical Trials Overview
Mobidiag Ltd Pipeline Products by Equipment Type
Mobidiag Ltd Pipeline Products by Indication
Mobidiag Ltd, Key Facts
Mobidiag Ltd, Major Products and Services
Mobidiag Ltd Number of Pipeline Products by Development Stage
Mobidiag Ltd Pipeline Products Summary by Development Stage
Amplidiag RESP-4 - Product Status
Amplidiag RESP-4 - Product Description
GeneSpress - Product Status
GeneSpress - Product Description
Novodiag Cartridge - Meningitis - Product Status
Novodiag Cartridge - Meningitis - Product Description
Novodiag COVID-19 + InfA/B - Product Status
Novodiag COVID-19 + InfA/B - Product Description
Novodiag RESP-4 - Product Status
Novodiag RESP-4 - Product Description
Novodiag System - Bloodstream Infections - Product Status
Novodiag System - Bloodstream Infections - Product Description
Novodiag System - Central Nervous System Infections - Product Status
Novodiag System - Central Nervous System Infections - Product Description
Novodiag System - Respiratory Infections - Product Status
Novodiag System - Respiratory Infections - Product Description
Novodiag System - Sepsis - Product Status
Novodiag System - Sepsis - Product Description
Novodiag System - Skin And Soft Tissue Infections - Product Status
Novodiag System - Skin And Soft Tissue Infections - Product Description
Mobidiag Ltd, Key Employees
Mobidiag Ltd, Other Locations
Glossary

★海外企業調査レポート[Mobidiag Ltd:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Companhia Energetica de Minas Gerais – CEMIG:企業のM&A・事業提携・投資動向
    Companhia Energetica de Minas Gerais - CEMIG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Companhia Energetica de Minas Gerais - CEMIG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Avisa Pharma Inc-医療機器分野:企業M&A・提携分析
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company’s product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; …
  • Pfenex Inc (PFNX)-製薬・医療分野:企業M&A・提携分析
    Summary Pfenex Inc (Pfenex) is a biologics company that develops biosimilar therapeutics. The company’s lead product candidate includes, PF582, a biosimilar candidate which is used for the treatment of retinal diseases. It also develops PF530, a biosimilar candidate for the treatment of multiple scl …
  • Charkit Chemical Company LLC:企業の戦略・SWOT・財務情報
    Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report Summary Charkit Chemical Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Vonage Holdings Corp:企業の戦略・SWOT・財務分析
    Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Vonage Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Purdue Pharma Canada:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma Canada, a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes antiseptics, laxa …
  • Garanti Technology:企業の戦略・SWOT・財務情報
    Garanti Technology - Strategy, SWOT and Corporate Finance Report Summary Garanti Technology - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aegion Corp (AEGN):企業の財務・戦略的SWOT分析
    Aegion Corp (AEGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):製薬・医療:M&Aディール及び事業提携情報
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …
  • Omnicell Inc (OMCL):企業の財務・戦略的SWOT分析
    Omnicell Inc (OMCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • LifeVantage Corp (LFVN):企業の財務・戦略的SWOT分析
    Summary LifeVantage Corp (LifeVantage) is a science-based nutraceutical company that manufactures and markets dietary supplements. The company provides products such as protandim, axio, physiq, truescience and canine health, among others. Its beauty products include cleansers, hand creams, micro lif …
  • Valeant Canada LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical products manufacturing company. The company offers products such as aczone, airomir, aldara, benzaclin topical gel, benzamycin, biacna topical gel, C.E.S. tablets, carbolith, ca …
  • Nippon Shokubai Co Ltd (4114):企業の財務・戦略的SWOT分析
    Nippon Shokubai Co Ltd (4114) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • RPG Life Sciences Ltd (RPGLIFE):企業の財務・戦略的SWOT分析
    Summary RPG Life Sciences Ltd (RPGLS), formerly Searle India Ltd, a subsidiary of RPG Enterprises Ltd, is an integrated pharmaceutical company that offers formulations, generics, synthetic and fermentation API products. The company offers API products such as anti-anginal, anti-helmentic, anti-convu …
  • Bioton SA (BIO):企業の戦略的SWOT分析
    Bioton SA (BIO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • AB-Biotics SA (ABB):医療機器:M&Aディール及び事業提携情報
    Summary AB-Biotics SA (AB-Biotics) is a provider of probiotics, pipeline products, specialty dietary supplements, and other functional ingredients. The company’s products comprise iron-containing ingredients, lactobacillus plantarum, probiotic products, gastrointestinal treatment products, proprieta …
  • Dova Pharmaceuticals Inc (DOVA):製薬・医療:M&Aディール及び事業提携情報
    Summary Dova Pharmaceuticals Inc (Dova), formerly PBM AKX Holdings LLC, is a clinical-stage pharmaceutical company that acquires, develops and commercializes therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (DOPTELET), a novel, oral thrombopoietin receptor a …
  • Snam S.p.A. (SRG):電力:M&Aディール及び事業提携情報
    Summary Snam S.p.A. (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. Snam Rete Gas, its subsidiary, transports natural gas; GNL Italia conducts regasification; and Stogit stores …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆